News and Announcements
Actinogen Medical Successfully Treats First Australian & US Patients & Reports Cash of $3.9m
- Published August 11, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Actinogen Medical (ASX:ACW) has recently provided a summary of its progress over the quarter ended June 30, 2017.
KEY TAKEAWAYS:
- The company achieved significant milestones with Actinogen’s Alzheimer’s disease trial, with the successful treatment of the first Australian and US patients.
- Represents a landmark in the global search for a new effective treatment.
- Additional trial sites in Australia, the US and the UK are expected soon commence enrolling patients, with the final patient planned to be enrolled by Q4 2018.
- Cash at 30th June 2017 of $3.989million.
The Company remains focused on ensuring the trial progresses as planned and looks forward to updating the market on its progress over the near medium term.
“We are delighted to have had such a strong momentum behind XanADu, a ground-breaking trial that shows Australia is leading the way in developing this promising new treatment for Alzheimer’s disease,” said Dr Bill Ketelbey, CEO of Actinogen Medical.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
